(Q57096837)

English

Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys (English)

0 references

object named as

Leyi Wang

1

0 references

7

object named as

Blanca Lupiani

0 references

author name string

Leyi Wang

1

0 references

Zhuoming Qin

2

0 references

Mary Pantin-Jackwood

3

0 references

Olivia Faulkner

4

0 references

David L Suarez

5

0 references

Maricarmen Garcia

6

0 references

Sanjay M Reddy

8

0 references

Yehia M Saif

9

0 references

Chang-Won Lee

10

0 references

David L. Suarez

5

0 references

Sanjay M. Reddy

8

0 references

Yehia M. Saif

9

0 references

language of work or name

0 references

publication date

19 October 2011

0 references

October 2011

0 references

number of pages

9

1 reference

based on heuristic

inferred from page(s)

0 references

29

0 references

45

0 references

7966-74

0 references

7966-7974

0 references

H3N2 influenza virus transmission from swine to turkeys, United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Triple reassortant H3N2 influenza A viruses, Canada, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Isolation and characterization of H3N2 influenza A virus from turkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Generation of avian influenza reassortant viruses of the H7N5 subtype as potential vaccine candidates to be used in the framework of a "DIVA" vaccination strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

A multiplexed immunoassay for detection of antibodies against avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

The synthesis of 4-methylumbelliferyl α-ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Appearance of serum antibodies against the avian influenza nonstructural 1 protein in experimentally infected chickens and turkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Overview of avian influenza DIVA test strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Detection of highly pathogenic avian influenza virus infection in vaccinated chicken flocks by monitoring antibodies against non-structural protein 1 (NS1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.067

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.08.067

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57096837&oldid=1953336297"